Mutation analysis of Gaucher disease patients from Argentina: High prevalence of the RecNciI mutation
Bru Cormand
Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Search for more papers by this authorTheresa L. Harboe
Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Search for more papers by this authorCristina Campoy
Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina
Search for more papers by this authorMariana Blanco
Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina
Search for more papers by this authorNéstor Chamoles
Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina
Search for more papers by this authorLluïsa Vilageliu
Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Search for more papers by this authorCorresponding Author
Daniel Grinberg
Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Departament de Genètica, Facultat de Biologia, Universitat de Barcelona; Av. Diagonal, 645; 08071 Barcelona, SpainSearch for more papers by this authorBru Cormand
Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Search for more papers by this authorTheresa L. Harboe
Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Search for more papers by this authorCristina Campoy
Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina
Search for more papers by this authorMariana Blanco
Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina
Search for more papers by this authorNéstor Chamoles
Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina
Search for more papers by this authorLluïsa Vilageliu
Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Search for more papers by this authorCorresponding Author
Daniel Grinberg
Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Departament de Genètica, Facultat de Biologia, Universitat de Barcelona; Av. Diagonal, 645; 08071 Barcelona, SpainSearch for more papers by this authorAbstract
Gaucher disease (GD) is caused by a deficiency of β-glucocerebrosidase activity mainly due to mutations in the gene coding for the enzyme. More than 100 mutations have been identified to date and their frequencies have been established in several populations, including Ashkenazi Jews, among whom the disease is particularly prevalent. In order to study the molecular pathology of the disease in patients from Argentina, we conducted a systematic search for mutations in the glucocerebrosidase gene. Genomic DNA from 31 unrelated GD patients was screened for seven previously described mutations: N370S (1226A→G), L444P (1448T→C), D409H (1342G→C), R463C (1504C→T), 1263del55, RecNciI, and RecTL. This allowed the identification of 77.4% of the GD alleles: N370S and RecNciI were the most prevalent mutations found (46.8% and 21% respectively). Southern analysis demonstrated three distinct patterns for the RecNciI alleles. In order to identify the remaining alleles, the full coding region of the gene, all the splice sites, and part of the promoter region were analyzed by single-strand conformational polymorphism analysis (SSCP) after polymerase chain reaction amplification. This extensive screening allowed the identification of 13 different mutations, accounting for 93% of the total number of GD alleles. Three novel missense mutations, I161S (599T→G), G265D (911G→A), and F411I (1348T→A), were detected. Twelve polymorphic sites within the glucocerebrosidase gene are in complete linkage disequilibrium and define two major haplotypes, “−” and “+”. Mutation N370S was always associated with the “−” haplotype, as described in other populations. Interestingly, the RecNciI alleles with the same Southern-blot pattern were always associated with the same haplotype. Am. J. Med. Genet. 80:343–351, 1998. © 1998 Wiley-Liss, Inc.
REFERENCES
-
Amaral O,
Pinto E,
Fortuna M,
Lacerda L,
Miranda M
(1996):
Type 1 Gaucher disease: Identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese.
Hum Mutat
8: 280–281.
10.1002/(SICI)1098-1004(1996)8:3<280::AID-HUMU15>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- Argaraña CE, Givogri I, Kremer RD, Gelbart T, Boldini CD (1995): Diagnóstico molecular de la enfermedad de Gaucher en pacientes argentinos. Medicina (B Aires) 55: 279–280.
- Balicki D, Beutler E (1995): Gaucher disease. Medicine (Baltimore) 74: 305–323.
- Beutler E, Gelbart T (1994): Two new Gaucher disease mutations. Hum Genet 93: 209–210.
- Beutler E, Grabowski GA (1995): Gaucher disease. In CR Scriver, AL Beaudet, WS Sly, D Valle (eds): “ The Metabolic and Molecular Bases of Inherited Disease.” 7th ed. New York: McGraw-Hill, pp 2641–2669.
- Beutler E, Gelbart T, Kuhl W, Sorge J, West C (1991): Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci USA 88: 10544–10547.
- Beutler E, Gelbart T, Kuhl W, Zimran A, West C (1992a): Mutations in Jewish patients with Gaucher disease. Blood 79: 1662–1666.
- Beutler E, West C, Gelbart T (1992b): Polymorphisms in the human glucocerebrosidase gene. Genomics 12: 795–800.
- Beutler E, Demina A, Gelbart T (1994): Glucocerebrosidase mutations in Gaucher disease. Mol Med 1: 82–92.
- Beutler E, Gelbart T, Demina A, Zimran A, Lecoutre P (1995): Five new Gaucher disease mutations. Blood Cells 21: 20–24.
- Chabás A, Cormand B, Balcells S, González-Duarte R, Casanova C, Colomer J, Vilageliu L, Grinberg D (1996): Neuronopathic and non-neuronopathic presentation of Gaucher disease patients with the third most common mutation (D409H) in Spain. J Inherit Metab Dis 19: 798–800.
- Cormand B, Vilageliu L, Burguera JM, Balcells S, Gonzalez-Duarte R, Grinberg D, Chabas A (1995): Gaucher disease in Spanish patients: Analysis of eight mutations. Hum Mutat 5: 303–309.
-
Cormand B,
Vilageliu L,
Balcells S,
González-Duarte R,
Chabás A,
Grinberg D
(1996):
Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the β-glucocerebrosidase gene in Gaucher's disease patients.
Hum Mutat
7: 272–274.
10.1002/(SICI)1098-1004(1996)7:3<272::AID-HUMU14>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
-
Cormand B,
Grinberg D,
Gort L,
Fiumara A,
Barone R,
Vilageliu L,
Chabás A
(1997a):
Two new mild homozygous mutations in Gaucher disease patients. Clinical signs and biochemical analyses.
Am J Med Genet
70: 437–443.
10.1002/(SICI)1096-8628(19970627)70:4<437::AID-AJMG19>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- Cormand B, Montfort M, Chabás A, Vilageliu L, Grinberg D (1997b): Genetic fine localization of the β-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: Implication for Gaucher disease. Hum Genet 100: 75–79.
-
Cormand B,
Grinberg D,
Gort L,
Chabás A,
Vilageliu L
(1998):
Molecular analysis and clinical findings in the Spanish Gaucher disease population: Putative haplotype of the N370S ancestral chromosome.
Hum Mutat
11: 295–305.
10.1002/(SICI)1098-1004(1998)11:4<295::AID-HUMU7>3.0.CO;2-6 CAS PubMed Web of Science® Google Scholar
- Dahl N, Lagerstrom M, Erikson A, Pettersson U (1990): Gaucher disease Type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet 47: 275–278.
- Glenn D, Gelbart T, Beutler E (1994): Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes. Hum Genet 93: 635–638.
- Grabowski GA (1993): Gaucher disease—Enzymology, genetics, and treatment. Adv Hum Genet 21: 377–441.
- Grabowski GA (1997): Gaucher disease: Gene frequencies and genotype/phenotype correlations. Genet Testing 1: 5–12.
- Guldberg P, Levy HL, Hanley WB, Koch R, Matalon R, Rouse BM, Trefz F, de la Cruz F, Henriksen KF, Güttler F (1996): Phenylalanine hydroxylase gene mutations in the United States: Report from the Maternal PKU Collaborative Study. Am J Hum Genet 59: 84–94.
- Horowitz M, Tzuri G, Eyal N, Berebi A, Kolodny EH, Brady RO, Barton NW, Abrahamov A, Zimran A (1993): Prevalence of 9 mutations among Jewish and non-Jewish Gaucher disease patients. Am J Hum Genet 53: 921–930.
- Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E (1989): The human glucocerebrosidase gene and pseudogene: Structure and evolution. Genomics 4: 87–96.
- Ida H, Iwasawa K, Kawame H, Rennert OM, Maekawa K, Eto Y (1995): Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: Absence of the common Jewish 84GG and 1226G mutations. Hum Genet 95: 717–720.
- Latham T, Grabowski A, Theophilus BDM, Smith FI (1990): Complex alleles of the acid β-glucosidase gene in Gaucher disease. Am J Hum Genet 47: 79–86.
- Latham TE, Theophilus BDM, Grabowski GA, Smith FI (1991): Heterogeneity of mutations in the acid β-glucosidase gene of Gaucher disease patients. DNA Cell Biol 10: 15–21.
- le Coutre P, Demina A, Beutler E, Beck M, Petrides PE (1997): Molecular analysis of Gaucher disease: Distribution of eight mutations and the complete gene deletion in 27 patients from Germany. Hum Genet 99: 816–821.
- Lewis BD, Nelson PV, Robertson EF, Morris CP (1994): Mutation analysis of 28 Gaucher disease patients—The Australasian experience. Am J Med Genet 49: 218–223.
- Lewontin RC (1988): On measures of gametic disequilibrium. Genetics 120: 849–852.
- Miller SA, Dyke DD, Polesky HF (1988): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
- Nelson PV, Carey WF, Morris CP, Lewis BD (1995): Mutation analysis of Australasian Gaucher disease patients. Am J Med Genet 58: 382.
- O'Neill RR, Tokoro T, Kozak CA, Brady RO (1989): Comparison of the chromosomal localization of murine and human glucocerebrosidase genes and of the deduced amino acid sequences. Proc Natl Acad Sci USA 86: 5049–5053.
- Orita M, Suzuki Y, Sekiya T, Hayashi K (1989): Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874–879.
- Rafi MA, Degala G, Zhang XL, Wenger DA (1993): Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency. Somat Cell Mol Genet 19: 1–7.
- Schnabel D, Schröder M, Sandhoff K (1991): Mutation in the sphingolipid activator protein 2 in a patient with a varient of Gaucher disease. FEBS Lett 284: 57–59.
- Sorge J, Gelbart T, West C, Westwood B, Beutler E (1985): Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene. Proc Natl Acad Sci USA 82: 5442–5445.
- Tayebi N, Herman J, Ginns EI, Sidransky E (1996): Genotype D399N/R463C in a patient with type 3 Gaucher disease previously assigned genotype N370S/R463C. Biochem Mol Med 57: 149–151.
- Tuteja R, Bembi B, Agosti E, Baralle FE (1993): 1448C mutation linked to the Pv1.1-genotype in Italian patients with Gaucher disease. Hum Mol Genet 2: 781–784.
- Uchiyama A, Tomatsu S, Kondo N, Suzuki Y, Shimozawa N, Fukuda S, Sukegawa K, Taki N, Inamori H, Orii T (1994): New Gaucher disease mutations in exon 10: A novel L444R mutation produces a new NciI site the same as L444P. Hum Mol Genet 3: 1183–1184.
- Walley AJ, Barth ML, Ellis I, Fensom AH, Harris A (1993): Gaucher's disease in the United Kingdom—Screening non-Jewish patients for the two common mutations. J Med Genet 30: 280–283.
- Zimran A, Horowitz M (1994): Rect1—A complex allele of the Glucocerebrosidase gene associated with a mild clinical course of Gaucher disease. Am J Med Genet 50: 74–78.
- Zimran A, Gelbart T, Beutler E (1990a): Linkage of the PvuII polymorphism with the common Jewish mutation for Gaucher disease. Am J Hum Genet 46: 902–905.
- Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E (1990b): A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder. J Clin Invest 85: 219–222.